ARENTFOX SCHIFF LLP for ORGANOGENESIS INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations and Discarded Products policy Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026 and CY2027) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R.6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELSEY GRISWOLD-BERGER | — |
| ELIZABETH HORNER | — |
| DAN RENBERG | — |
| OLIVER SPURGEON III | — |
| BLAKE THELANDER | — |
Health Issues HCR
Food and Drug Administration policy on chronic wound healing products
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN RENBERG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.